MiR-195 also canonically inhibits NOTCH2 [295] and BCL2L11 [296] in CRC cells, providing more pathways of tumor suppression through preventing EMT and promoting apoptosis, respectively. The gene discussed is BCL2L11; the disease is colorectal carcinoma.